Heparin free coating on PLA membranes for enhanced hemocompatibility via iCVD

Applied Surface Science

Volumn 433, Issue , 2018, Pages 869-878

  Wang, Hui ^a,b   Shi, Xiao ^c   Gao, Ailin ^b   Lin, Haibo ^b   Chen, Yongliang ^b   Ye, Yumin ^c   He, Jidong ^a   Liu, Fu ^b   Deng, Gang ^d  

^a QINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NINGBO INSTITUTE OF MATERIALS TECHNOLOGY AND ENGINEERING   (China)

^c NINGBO UNIVERSITY   (China)

^d Central Blood Station of Ningbo   (China)

Author keywords

Anticoagulant; Coating; Hemocompatibility; iCVD; Membrane

Indexed keywords

CHEMICAL VAPOR DEPOSITION; COATINGS; CROSSLINKING; PLATELETS; POLYSACCHARIDES; WEIGHING;

ANTICOAGULANT; COMPLEMENT ACTIVATIONS; HEMOCOMPATIBILITY; HYDRATION INTERACTION; ICVD; INITIATED CHEMICAL VAPOR DEPOSITIONS; MEMBRANE SURFACE; PLATELET ADHESION;

MEMBRANES;

EID: 85032015078     PISSN: 01694332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apsusc.2017.10.123     Document Type: Article

References (42)

1. Fischer, K.G., Essentials of anticoagulation in hemodialysis. Hemodialysis International Symposium on Home Hemodialysis, 11, 2007, 178.
2. Murray, P.T., Reddy, B.V., Grossman, E.J., Hammes, M.S., Trevino, S., Ferrell, J., Tang, I., Hursting, M.J., Shamp, T.R., Swan, S.K., A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease. Kidney Int. 66 (2004), 2446–2453.
3. Suranyi, M., Chow, J.S., Review anticoagulation for haemodialysis. Nephrology, 15, 2010, 386.
4. Frank, R.D., Weber, J., Dresbach, H., Thelen, H., Weiss, C., Floege, J., Role of contact system activation in hemodialyzer-induced thrombogenicity. Kidney Int. 60 (2001), 1972–1981.
5. Româo, J.E. Jr., Fadil Sabbaga, E., Marcondes, M., Hemodialysis without anticoagulant: hemostasis parameters, fibrinogen kinetic, and dialysis efficiency. Nephrol. Dial. Transplant. 12 (1997), 106–110.
6. Keller, F., Seemann, J., Preuschof, L., Offermann, G., Risk factors of system clotting in heparin-free haemodialysis. Nephrol. Dial. Transplant. 5 (1990), 802–807.
7. Gritters, M., Borgdorff, P., Grooteman, M.P.C., Schoorl, M., Schoorl, M., Bartels, P.C.M., Tangelder, G.J., Nubé, M.J., Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?. Nephrol. Dial. Transplant. 23 (2008), 2911–2917.
8. Shen, J.I., Winkelmayer, W.C., Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis. Am. J. Kidney Dis. 60 (2012), 473–486.
9. Sasaki, M., Development of vitamin E-modified polysulfone membrane dialyzers. J. Artif. Organs 9 (2006), 50–60.
10. Morena, M., Jaussent, I., Chalabi, L., Bargnoux, A.S., Dupuy, A.M., Badiou, S., Rakic, C., Thomas, M., Canaud, B., Cristol, J.P., Biocompatibility of heparin-grafted hemodialysis membranes: impact on monocyte chemoattractant protein-1 circulating level and oxidative status. Hemodial. Int. 14 (2010), 403–410.
11. Lavaud, S., Canivet, E., Wuillai, A., Maheut, H., Randoux, C., Bonnet, J.M., Renaux, J.L., Chanard, J., Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane. Nephrol. Dial. Transplant. 18 (2003), 2097–2104.
12. Chanard, J., Lavaud, S., Maheut, H., Kazes, I., Vitry, F., Rieu, P., The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane. Nephrol. Dial. Transplant. 23 (2008), 2003–2009.
13. Xiang, T., Zhang, L.-S., Wang, R., Xia, Y., Su, B.-H., Zhao, C.-S., Blood compatibility comparison for polysulfone membranes modified by grafting block and random zwitterionic copolymers via surface-initiated ATRP. J. Colloid Interface Sci. 432 (2014), 47–56.
14. Zhao, J., Shi, Q., Yin, L., Luan, S., Shi, H., Song, L., Yin, J., Stagnaro, P., Polypropylene modified with 2-hydroxyethyl acrylate-g-2-methacryloyloxyethyl phosphorycholine and its hemocompatibility. Appl. Surf. Sci. 256 (2010), 7071–7076.
15. Li, J., Liu, F., Yu, X., Wu, Z., Wang, Y., Xiong, Z., He, J., APTES assisted surface heparinization of polylactide porous membranes for improved hemocompatibility. RSC Adv. 6 (2016), 42684–42692.
16. Wang, L., Cai, Y., Jing, Y., Zhu, B., Zhu, L., Xu, Y., Route to hemocompatible polyethersulfone membranes via surface aminolysis and heparinization. J. Colloid Interface Sci. 422 (2014), 38–44.
17. Cheng, C., Sun, S., Zhao, C., Progress in heparin and heparin-like/mimicking polymer-functionalized biomedical membranes. J. Mater. Chem. B 2 (2014), 7649–7672.
18. Liu, T., Zeng, Z., Liu, Y., Wang, J., Maitz, M.F., Wang, Y., Liu, S., Chen, J., Huang, N., Surface modification with dopamine and heparin/poly-l-lysine nanoparticles provides a favorable release behavior for the healing of vascular stent lesions. ACS Appl. Mater. Interfaces 6 (2014), 8729–8743.
19. Perrenoud, I., Antunesrangel, E., Ciprianomota, R., Pintodurrant, S., Frederickcruz, N.C. Da, Evaluation of blood compatibility of plasma deposited heparin-like films and SF6 plasma treated surfaces. Mater. Res. 13 (2010), 95–98.
20. Tamada, Y., Murata, M., Hayashi, T., Goto, K., Anticoagulant mechanism of sulfonated polyisoprenes. Biomaterials, 23, 2002, 1375.
21. Mammadov, R., Mammadov, B., Toksoz, S., Aydin, B., Yagci, R., Tekinay, A.B., Guler, M.O., Heparin mimetic peptide nanofibers promote angiogenesis. Biomacromolecules 12 (2011), 3508–3519.
22. Cheng, C., Li, S., Thomas, A., Kotov, N.A., Haag, R., Functional graphene nanomaterials based architectures: biointeractions, fabrications, and emerging biological applications. Chem. Rev. 117 (2017), 1826–1914.
23. Arlov, Ø., Aachmann, F.L., Sundan, A., Espevik, T., Skjåkbræk, G., Heparin-like properties of sulfated alginates with defined sequences and sulfation degrees. Biomacromolecules 15 (2014), 2744–2750.
24. Dernedde, J., Rausch, A., Weinhart, M., Enders, S., Tauber, R., Licha, K., Schirner, M., Zügel, U., Von, B.A., Haag, R., Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 19679–19684.
25. Li, L., Cheng, C., Xiang, T., Tang, M., Zhao, W., Sun, S., Zhao, C., Modification of polyethersulfone hemodialysis membrane by blending citric acid grafted polyurethane and its anticoagulant activity. J. Membr. Sci. 405-406 (2012), 261–274.
26. Nie, S., Xue, J., Lu, Y., Liu, Y., Wang, D., Sun, S., Ran, F., Zhao, C., Improved blood compatibility of polyethersulfone membrane with a hydrophilic and anionic surface. Colloids Surf. B Biointerfaces 100 (2012), 116–125.
27. Ran, F., Nie, S., Li, J., Su, B., Sun, S., Zhao, C., Heparin-like macromolecules for the modification of anticoagulant biomaterials. Macromol. Biosci. 12 (2012), 116–125.
28. Tang, M., Xue, J., Yan, K., Xiang, T., Sun, S., Zhao, C., Heparin-like surface modification of polyethersulfone membrane and its biocompatibility. J. Colloid Interface Sci., 386, 2012, 428.
29. Alf, M.E., Asatekin, A., Barr, M.C., Baxamusa, S.H., Chelawat, H., Ozaydin-Ince, G., Petruczok, C.D., Sreenivasan, R., Tenhaeff, W.E., Trujillo, N.J., Chemical vapor deposition of conformal functional, and responsive polymer films. Adv. Mater., 22, 2010, 1993.
30. Coclite, A.M., Howden, R.M., Borrelli, D.C., Petruczok, C.D., Yang, R., Ugur, A., Chen, N., Lee, S., Jo, W.J., Liu, A., 25th anniversary article: CVD polymers: a new paradigm for surface modification and device fabrication. Adv. Mater. 25 (2013), 5392–5423.
31. Yang, R., Asatekin, A., Gleason, K.K., Design of conformal, substrate-independent surface modification for controlled protein adsorption by chemical vapor deposition (CVD). Soft Matter 8 (2011), 31–43.
32. Sun, M., Wu, Q., Xu, J., He, F., Brown, A.P., Ye, Y., Vapor-based grafting of crosslinked poly(N-vinyl pyrrolidone) coatings with tuned hydrophilicity and anti-biofouling properties. J. Mater. Chem. B 4 (2016), 2669–2678.
33. Gao, A., Liu, F., Shi, H., Xue, L., Controllable transition from finger-like pores to inter-connected pores of PLLA membranes. J. Membr. Sci. 478 (2015), 96–104.
34. Li, S.-S., Xie, Y., Xiang, T., Ma, L., He, C., Sun, S.-d, Zhao, C.-S., Heparin-mimicking polyethersulfone membranes–hemocompatibility, cytocompatibility, antifouling and antibacterial properties. J. Membr. Sci. 498 (2016), 135–146.
35. Chakrabartya, B., Ghoshal, A.K., Purkait, M.K., Preparation, characterization and performance studies of polysulfone membranes using PVP as an additive. J. Membr. Sci. 315 (2008), 36–47.
36. Li, J., Liu, F., Qin, Y., He, J., Xiong, Z., Deng, G., Li, Q., A novel natural hirudin facilitated anti-clotting polylactide membrane via hydrogen bonding interaction. J. Membr. Sci. 523 (2017), 505–514.
37. Nie, S., Tang, M., Cheng, C.S., Yin, Z., Wang, L., Sun, S., Zhao, C., Biologically inspired membrane design with a heparin-like interface: prolonged blood coagulation, inhibited complement activation, and bio-artificial liver related cell proliferation. Biomater. Sci. 2 (2013), 98–109.
38. Qin, H., Sun, C., He, C., Wang, D., Cheng, C., Nie, S., Sun, S., Zhao, C., High efficient protocol for the modification of polyethersulfone membranes with anticoagulant and antifouling properties via in situ cross-linked copolymerization. J. Membr. Sci. 468 (2014), 172–183.
39. Tang, M., Xue, J., Yan, K., Xiang, T., Sun, S., Zhao, C., Heparin-like surface modification of polyethersulfone membrane and its biocompatibility. J. Colloid Interface Sci. 386 (2012), 428–440.
40. Zhou, H., Cheng, C., Qin, H., Ma, L., He, C., Nie, S., Zhang, X., Fu, Q., Zhao, C., Self-assembled 3D biocompatible and bioactive layer at the macro-interface via graphene-based supermolecules. Polym. Chem. 5 (2014), 3563–3575.
41. Zheng, S., Yang, Q., Mi, B., Novel antifouling surface with improved hemocompatibility by immobilization of polyzwitterions onto silicon via click chemistry. Appl. Surf. Sci. 363 (2016), 619–626.
42. Björk, I., Lindahl, U., Mechanism of the anticoagulant action of heparin. Mol. Cell. Biochem. 48 (1982), 161–182.